Ikris Pharma Network
Ikris Pharma
Ikris Pharma Network | India's Leading Named Patient Medicine Access Platform
Hero 1 Hero 2 Hero 3

Leading Company in the Field of
Named Patient Program

Access to unapproved and unregistered medicines through compliant Named Patient Program pathways—backed by robust regulatory expertise, 100% compliance with GDP, and a strong global network.

Named Patient Program

A Trusted Compliant Partner For Innovative Medicines

We ensure authentic access to innovative & unapproved medicines through a trusted global manufacturers and stockists network, fully aligned with Good Distribution Practice (GDP) standards. With strong regulatory oversight and adherence to applicable guidelines, we maintain the highest levels of safety and compliance.

Safety & Transparency
Temperature-Controlled Logistics
Quality & Integrity
EU-Compliant Standards
Learn more

From Search & Approval
to Global Medicine Access

When access goes beyond borders, this is the path your medicine follows. Get started with our help

Access Request

Submit your request to initiate access pathway

Medicine Verification

Reviewing documents for medical and regulatory compliance

Quotation & Timelines

Transparent pricing with clear timelines for access

Regulatory Approval

Managing approvals in line with regulatory requirements

Controlled Handling

Maintaining product integrity through controlled temperature handling

Secure Delivery

Safe, reliable delivery with complete end-to-end traceability

Trusted Expertise in Compliant Global Medicine Access

We support patients and healthcare providers through compliant pathways, trusted sourcing, and reliable logistics ensuring timely access to essential medicines when it matters most.

10+

Years of Expertise

15,000+

Patients Served

1.5 Million+

Product Lines

24/7

Temperature Monitoring

50+

Hospitals & Institutions Served

Is it legal in India to import

We are a leading Indian company in the field of the Named Patient Program, helping patients and healthcare providers access life-saving therapies not yet available in the Indian market. Our mission is simple: compliant, reliable, and timely access to medicines that matter.

Document Required
Regulatory Approvals
Scope of import
Permitted Use & Restrictions
Named Patient Program

Medicines by Therapeutic Category

Supporting patients and doctors in finding the right therapies.

Oncology

Oncology

Therapeutics targeting cancers through chemotherapy, targeted therapies, immunotherapies, and monoclonal antibodies.

Read more
Hematology

Hematology

Drugs for blood disorders like leukemia, lymphoma, anemia, and hemophilia using chemotherapies, growth factors, and clotting agents.

Read more
Rare Disease

Rare Disease

Specialized orphan drugs and gene therapies for uncommon genetic, metabolic, or orphan conditions affecting small patient populations.

Read more
Endocrinology

Endocrinology

Medicines regulating hormones for diabetes, thyroid disorders, and adrenal conditions with insulins, thyroid replacements, and corticosteroids.

Read more
Hepatology

Hepatology

Pharmaceuticals treating liver diseases including hepatitis, cirrhosis, and fatty liver using antivirals, antifibrotics, and immunosuppressants

Read more
Immunology

Immunology

Agents modulating immune system for autoimmune diseases, allergies, and immunodeficiencies via biologics and immunosuppressants.

Read more
Nephrology

Nephrology

Drugs addressing kidney disorders like chronic kidney disease, glomerulonephritis, and dialysis support with antihypertensives and erythropoietin.

Read more
Neurology

Neurology

Medications treating central nervous system disorders like epilepsy, Parkinson's, migraines, and multiple sclerosis with antiepileptics, antiparkinsonians, and analgesics

Read more
Pulmonology

Pulmonology

Drugs for respiratory conditions including asthma, COPD, cystic fibrosis, and pneumonia using bronchodilators, corticosteroids, and antibiotics.

Read more
Cardiology

Cardiology

Agents managing heart diseases such as hypertension, arrhythmias, heart failure, and thrombosis via antihypertensives, statins, and anticoagulants

Read more
Misc

Misc

Uncategorized pharmaceuticals covering diverse therapies not fitting specific disease areas.

Read more

Improving Access to Innovative Therapies

Providing structured product categories with safe, compliant, and reliable global access.

No Image

Journavx

Uncategorized pharmaceuticals covering diverse therapies not fitting specific disease areas.

Read more
Dantrium

Dantrium

Uncategorized pharmaceuticals covering diverse therapies not fitting specific disease areas.

Read more
No Image

Elrexfio

Uncategorized pharmaceuticals covering diverse therapies not fitting specific disease areas.

Read more
No Image

Elrexfio

Uncategorized pharmaceuticals covering diverse therapies not fitting specific disease areas.

Read more
Named Patient Program

Every Degree Matters for Medicine Safety

Temperature-sensitive medicines require strict, uninterrupted control from storage to delivery, as even minimal variation can impact safety and effectiveness. With temperature ranges from ambient (15–25°C) to refrigerated (2–8°C) and frozen (-20°C), each shipment is managed under a fully compliant supply chain using WHO GDP-aligned practices and real-time monitoring to ensure optimal condition upon arrival.

End-to-End Temperature Control
Multi-Range Cold Chain Expertise
Real-Time Temperature Monitoring Systems
Global Compliant Delivery Network
Learn more

Request medicine with Valid Prescription

A secure, compliant pathway enabling access to essential prescribed medicines across borders.

1

Click on request to share your details to initiate your request.

2

Securely upload a valid prescription from your doctor.

3

Verification for authenticity and regulatory compliance requirements

4

Receive treatment details, pricing, and delivery timelines.

Content Hub

Providing structured product categories with safe, compliant, and reliable global access.

Named Patient Program

FDA Approves First Intranasal Diuretic, Enbumyst

nbumyst (bumetanide nasal spray), developed by Corstasis Therapeutics, has received approval from the U.S. Food and Drug Administration (FDA).

Read More

FDA Approves First Intranasal Diuretic, Enbumyst

nbumyst (bumetanide nasal spray), developed by Corstasis Therapeutics, has received approval from the U.S. Food and Drug Administration (FDA).

Read More

Get in touch

Reach out, and let's create a universe of possibilities together!

Let's us help!

We get back to you shortly during our working hours.

Trusted by NPM

Discuss Your
Problem

Trusted support you can rely on.

Mail Us At:

info@namedpatientprogram.com

Contact Us:

+91 9810469557

Latest News and Updates

Stay informed with our recent developments, insights, and announcements

Named Patient Program

FDA Approves First Intranasal Diuretic, Enbumyst

nbumyst (bumetanide nasal spray), developed by Corstasis Therapeutics, has received approval from the U.S. Food and Drug Administration (FDA).

Read More

FDA FDA Approves First Intranasal Diuretic, Enbumyst

nbumyst (bumetanide nasal spray), developed by Corstasis Therapeutics, has received approval from the U.S. Food and Drug Administration (FDA).

Read More

Frequently Asked
Questions

Here are answers to questions we're often asked.

Find your Answers?
Indian Pharma Network Footer